Altered expression and functions of serotonin 5‐HT1A and 5‐HT1B receptors in knock‐out mice lacking the 5‐HT transporter

By taking up serotonin (5‐hydroxytryptamine, 5‐HT) released in the extracellular space, the 5‐HT transporter (5‐HTT) regulates central 5‐HT neurotransmission. Possible adaptive changes in 5‐HT neurotransmission in knock‐out mice that do not express the 5‐HT transporter were investigated with special focus on 5‐HT1A and 5‐HT1B receptors. Specific labelling with radioligands and antibodies, and competitive RT‐PCR, showed that 5‐HT1A receptor protein and mRNA levels were significantly decreased in the dorsal raphe nucleus (DRN), increased in the hippocampus and unchanged in other forebrain areas of 5‐HTT–/– vs. 5‐HTT+/+ mice. Such regional differences also concerned 5‐HT1B receptors because a decrease in their density was found in the substantia nigra (−30%) but not the globus pallidus of mutant mice. Intermediate changes were noted in 5‐HTT+/– mice compared with 5‐HTT+/+ and 5‐HTT–/– animals. Quantification of [35S]GTP‐γ‐S binding evoked by potent 5‐HT1 receptor agonists confirmed such changes as a decrease in this parameter was noted in the DRN (−66%) and the substantia nigra (−30%) but not other brain areas in 5‐HTT–/– vs. 5‐HTT+/+ mice. As expected from actions mediated by functional 5‐HT1A and 5‐HT1B autoreceptors, a decrease in brain 5‐HT turnover rate after i.p. administration of ipsapirone (a 5‐HT1A agonist), and an increased 5‐HT outflow in the substantia nigra upon local application of GR 127935 (a 5‐HT1B/1D antagonist) were observed in 5‐HTT+/+ mice. Such effects were not detected in 5‐HTT–/– mice, further confirming the occurrence of marked alterations of 5‐HT1A and 5‐HT1B autoreceptors in these animals.

[1]  L. Mancini,et al.  Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  P. McGuffin,et al.  Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter , 1994, Neuropharmacology.

[3]  I. Stanford,et al.  Differential Actions of Serotonin, Mediated by 5-HT1Band 5-HT2C Receptors, on GABA-Mediated Synaptic Input to Rat Substantia Nigra Pars Reticulata Neurons In Vitro , 1996, The Journal of Neuroscience.

[4]  M. Hamon,et al.  Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies , 1999, Neuroscience.

[5]  H. V. Van Tol,et al.  Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. , 1990, The Journal of biological chemistry.

[6]  P. Pauwels,et al.  Autoradiography of Serotonin 5‐HT1A Receptor‐Activated G Proteins in Guinea Pig Brain Sections by Agonist‐Stimulated [35S]GTPγS Binding , 1998, Journal of neurochemistry.

[7]  X. Langlois,et al.  Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5-hydroxytryptamine1A receptor , 1994, Neuroscience.

[8]  A. Sleight,et al.  Effects of the 5-HT1D receptor antagonist GR127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis , 1995, Neuropharmacology.

[9]  R. Hen,et al.  The mouse 5-hydroxytryptamine 1B receptor is localized predominantly on axon terminals , 1994, Neuroscience.

[10]  M. Martres,et al.  Chronic alcoholization alters the expression of 5-HT1A and 5-HT1B receptor subtypes in rat brain. , 1995, European journal of pharmacology.

[11]  G. Aghajanian,et al.  Hyperpolarization of serotonergic neurons by serotonin and LSD: Studies in brain slices showing increased K+ conductance , 1984, Brain Research.

[12]  M Briley,et al.  Neurobiological mechanisms involved in antidepressant therapies. , 1993, Clinical neuropharmacology.

[13]  D. Kooy,et al.  Organization of the striatum: Collateralization of its Efferent Axons , 1985, Brain Research.

[14]  L. Lanfumey,et al.  The main features of central 5-HT1 receptors. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[15]  X. Langlois,et al.  Immunolabeling of Central Serotonin 5‐HT1Dβ Receptors in the Rat, Mouse, and Guinea Pig with a Specific Anti‐Peptide Antiserum , 1995, Journal of neurochemistry.

[16]  C. Montigny,et al.  Current advances and trends in the treatment of depression. , 1994, Trends in pharmacological sciences.

[17]  R. Samanin,et al.  Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram , 1995, Brain Research.

[18]  M. Hamon,et al.  Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. , 1988, The Journal of pharmacology and experimental therapeutics.

[19]  S. Svebak,et al.  Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects. , 1990, The Journal of clinical psychiatry.

[20]  M Briley,et al.  Serotonin autoreceptor subsensitivity and antidepressant activity. , 1990, European journal of pharmacology.

[21]  J. Chauveau,et al.  Biochemical and Pharmacological Characterization of Serotonin‐O‐Carboxymethylglycyl[125I]Iodotyrosinamide5 a New Radioiodinated Probe for 5‐HT1B and 5‐HT1D Binding Sites , 1992, Journal of Neurochemistry.

[22]  L. Lanfumey,et al.  Somato-dendritic 5-HT1A Autoreceptors in the Dorsal Raphe Nucleus; Pharmacological and Functional Properties , 1991 .

[23]  M. Fujita,et al.  Cellular localization of serotonin transporter mRNA in the rat brain , 1993, Neuroscience Letters.

[24]  Z. Kruk,et al.  Effects of 21 days treatment with fluoxetine on stimulated endogenous 5-hydroxytryptamine overflow in the rat dorsal raphe and suprachiasmatic nucleus studies using fast cyclic voltammetry in vitro , 1994, Brain Research.

[25]  R. Tao,et al.  The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. , 1991, European journal of pharmacology.

[26]  M. Hamon,et al.  Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse. , 1994, European journal of pharmacology.

[27]  M. Hamon,et al.  The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. , 1995, European journal of pharmacology.

[28]  R. Hen,et al.  Regulation of [3H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice , 1995, Neuroreport.

[29]  M. Hamon,et al.  [3H]Alnespirone: a novel specific radioligand of 5-HT1A receptors in the rat brain. , 1997, European journal of pharmacology.

[30]  D. Murphy,et al.  Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. , 1998, Molecular pharmacology.

[31]  P. Pauwels 5-HT 1B/D receptor antagonists. , 1997, General pharmacology.

[32]  C. Waeber,et al.  5-Hydroxytryptamine1A and 5-hydroxytryptamine1B receptors stimulate [35S]guanosine-5'-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography. , 1997, Molecular pharmacology.

[33]  K. Lesch,et al.  Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter , 1999, Neuroscience Letters.

[34]  G. Aghajanian,et al.  Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons. , 1987, European journal of pharmacology.

[35]  M. Hamon,et al.  Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  P. Seeburg,et al.  Molecular cloning and characterization of a rat brain cDNA encoding a 5‐hydroxytryptamine1B receptor. , 1991, The EMBO journal.

[37]  M. Millan,et al.  Potentiation of the Fluoxetine‐Induced Increase in Dialysate Levels of Serotonin (5‐HT) in the Frontal Cortex of Freely Moving Rats by Combined Blockade of 5‐HT1A and 5‐HT1B Receptors with WAY 100,635 and GR 127,935 , 1997, Journal of neurochemistry.

[38]  J. Laitinen,et al.  Guanosine 5′‐(γ‐[35S]Thio)triphosphate Autoradiography Allows Selective Detection of Histamine H3 Receptor‐Dependent G Protein Activation in Rat Brain Tissue Sections , 1998, Journal of neurochemistry.

[39]  S. Beck,et al.  Fluoxetine selectively alters 5-hydroxytryptamine1A and gamma-aminobutyric acidB receptor-mediated hyperpolarization in area CA1, but not area CA3, hippocampal pyramidal cells. , 1997, The Journal of pharmacology and experimental therapeutics.

[40]  D. Murphy,et al.  Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. , 1999, The Journal of pharmacology and experimental therapeutics.

[41]  K. Perry,et al.  Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. , 1975, The Journal of pharmacology and experimental therapeutics.

[42]  A. Levey,et al.  Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  S. Clissold,et al.  Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. , 1991, Drugs.

[44]  Claudette Boni,et al.  Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine , 2000, Neuropharmacology.

[45]  K. Lesch Molecular Biology, Pharmacology, and Genetics of the Serotonin Transporter: Psychobiological and Clinical Implications , 2000 .

[46]  J. Neumaier,et al.  Chronic Fluoxetine Reduces Serotonin Transporter mRNA and 5-HT1B mRNA in a Sequential Manner in the Rat Dorsal Raphe Nucleus , 1996, Neuropsychopharmacology.

[47]  S. Haj-Dahmane,et al.  K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: Anin vitro electrophysiological study , 1991, Neuroscience.

[48]  C. Gerfen,et al.  Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study , 1988, Brain Research.

[49]  Klaus-Peter Lesch,et al.  Cellular localization and expression of the serotonin transporter in mouse brain , 1997, Brain Research.

[50]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[51]  J. del Río,et al.  Acute or chronic antidepressants do not modify [125I]cyanopindolol binding to 5-HT1B receptors in rat brain. , 1991, European journal of pharmacology.

[52]  C. de Montigny,et al.  A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. , 1990, The Journal of clinical psychiatry.

[53]  K. Ryan,et al.  3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one: A Potent and Selective Serotonin (5-HT1B) Agonist and Rotationally Restricted Phenolic Analogue of 5-Methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole. , 1991 .

[54]  S. Haj-Dahmane,et al.  Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. , 1994, The Journal of pharmacology and experimental therapeutics.

[55]  C. de Montigny,et al.  Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1A Receptors , 1998, The Journal of Neuroscience.

[56]  R. Hen,et al.  Of mice and flies: commonalities among 5-HT receptors. , 1992, Trends in pharmacological sciences.